Exercise Intervention for Young Cancer Survivors
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems the focus is on integrating exercise into your care, so you may not need to stop your medications, but it's best to discuss this with the trial coordinators.
What data supports the effectiveness of this treatment for young cancer survivors?
Research shows that physical activity interventions are safe and beneficial for young cancer survivors, improving health-related outcomes like physical functioning and quality of life. Studies highlight the positive impact of personalized exercise plans, wearable devices, and goal setting in enhancing recovery and overall well-being.12345
Is exercise intervention safe for young cancer survivors?
How is the physical activity intervention treatment unique for young cancer survivors?
The physical activity intervention for young cancer survivors is unique because it is tailored to individual needs, often using wearable devices and goal setting to improve health outcomes. Unlike traditional treatments, it focuses on enhancing overall well-being and recovery through personalized exercise plans, which can help mitigate symptoms like fatigue and anxiety.2591011
What is the purpose of this trial?
The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in adolescents and young adults (AYA). Our central hypothesis is that integration of exercise interventions into standard post-cancer directed treatment care will be acceptable and feasible while improving patients' pain, decreasing the cumulative dose of pain medication and improving patients' functional and psychosocial outcomes as compared to patients who only receive standard post-cancer directed treatment care.
Research Team
Smita Dandekar, MD
Principal Investigator
Penn State College of Medicine
Eligibility Criteria
This trial is for Adolescent and Young Adult (AYA) cancer survivors, aged 17-39, who are less than a year post-cancer therapy. They must speak English, be stable post-treatment, able to consent and attend three visits at Penn State Health Milton S. Hershey Medical Center. Participants with chronic pain and access to wifi-enabled devices can join; those over a year post-therapy or with contraindications to exercise cannot.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments including psychosocial questionnaires, physical activity level, and functional outcomes
Treatment
Participants receive physical activity intervention coupled with standard post-cancer directed treatment care
Follow-up
Participants are monitored for changes in pain levels, physical activity, and functional outcomes
Treatment Details
Interventions
- Physical activity intervention
- Standard post-cancer directed treatment care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor